nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—HTR3A—enteric nervous system—Crohn's disease	0.167	0.467	CbGeAlD
Tapentadol—HTR3A—myenteric nerve plexus—Crohn's disease	0.127	0.354	CbGeAlD
Tapentadol—UGT1A9—digestive system—Crohn's disease	0.0163	0.0455	CbGeAlD
Tapentadol—UGT2B7—digestive system—Crohn's disease	0.0131	0.0367	CbGeAlD
Tapentadol—Lung disorder—Mesalazine—Crohn's disease	0.00965	0.021	CcSEcCtD
Tapentadol—HTR3A—digestive system—Crohn's disease	0.00959	0.0268	CbGeAlD
Tapentadol—Feeling hot—Mesalazine—Crohn's disease	0.0087	0.019	CcSEcCtD
Tapentadol—Withdrawal syndrome—Prednisone—Crohn's disease	0.00865	0.0189	CcSEcCtD
Tapentadol—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.0083	0.0181	CcSEcCtD
Tapentadol—Breast disorder—Mercaptopurine—Crohn's disease	0.00825	0.018	CcSEcCtD
Tapentadol—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.00737	0.0161	CcSEcCtD
Tapentadol—SLC6A4—digestive system—Crohn's disease	0.00731	0.0204	CbGeAlD
Tapentadol—Abnormal dreams—Mesalazine—Crohn's disease	0.00675	0.0147	CcSEcCtD
Tapentadol—CYP2C19—digestive system—Crohn's disease	0.00606	0.0169	CbGeAlD
Tapentadol—Immune system disorder—Mercaptopurine—Crohn's disease	0.00571	0.0124	CcSEcCtD
Tapentadol—Disorientation—Mesalazine—Crohn's disease	0.00554	0.0121	CcSEcCtD
Tapentadol—Malnutrition—Mercaptopurine—Crohn's disease	0.0055	0.012	CcSEcCtD
Tapentadol—Suicidal ideation—Prednisone—Crohn's disease	0.00515	0.0112	CcSEcCtD
Tapentadol—Lethargy—Mesalazine—Crohn's disease	0.00506	0.011	CcSEcCtD
Tapentadol—Osteoarthritis—Mesalazine—Crohn's disease	0.00496	0.0108	CcSEcCtD
Tapentadol—CYP2C9—digestive system—Crohn's disease	0.0047	0.0131	CbGeAlD
Tapentadol—Arthralgia—Mercaptopurine—Crohn's disease	0.00468	0.0102	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00465	0.0101	CcSEcCtD
Tapentadol—Memory impairment—Prednisone—Crohn's disease	0.0046	0.01	CcSEcCtD
Tapentadol—Abdominal discomfort—Azathioprine—Crohn's disease	0.00451	0.00984	CcSEcCtD
Tapentadol—Oedema—Mercaptopurine—Crohn's disease	0.00449	0.00979	CcSEcCtD
Tapentadol—Breast disorder—Mesalazine—Crohn's disease	0.00448	0.00977	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00446	0.00974	CcSEcCtD
Tapentadol—Nasopharyngitis—Mesalazine—Crohn's disease	0.00443	0.00967	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00437	0.00954	CcSEcCtD
Tapentadol—Skin disorder—Mercaptopurine—Crohn's disease	0.00436	0.00951	CcSEcCtD
Tapentadol—Infestation NOS—Azathioprine—Crohn's disease	0.00419	0.00915	CcSEcCtD
Tapentadol—Infestation—Azathioprine—Crohn's disease	0.00419	0.00915	CcSEcCtD
Tapentadol—Abdominal discomfort—Mesalazine—Crohn's disease	0.00411	0.00896	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00409	0.00892	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00398	0.00869	CcSEcCtD
Tapentadol—Pollakiuria—Mesalazine—Crohn's disease	0.00396	0.00863	CcSEcCtD
Tapentadol—Decreased appetite—Mercaptopurine—Crohn's disease	0.0039	0.00851	CcSEcCtD
Tapentadol—Weight decreased—Mesalazine—Crohn's disease	0.00388	0.00846	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00387	0.00845	CcSEcCtD
Tapentadol—Infestation NOS—Mesalazine—Crohn's disease	0.00382	0.00833	CcSEcCtD
Tapentadol—Infestation—Mesalazine—Crohn's disease	0.00382	0.00833	CcSEcCtD
Tapentadol—Depression—Mesalazine—Crohn's disease	0.00381	0.00831	CcSEcCtD
Tapentadol—Urinary tract infection—Mesalazine—Crohn's disease	0.00371	0.0081	CcSEcCtD
Tapentadol—SLC6A2—lymph node—Crohn's disease	0.00368	0.0103	CbGeAlD
Tapentadol—CYP2D6—digestive system—Crohn's disease	0.00352	0.00984	CbGeAlD
Tapentadol—Immune system disorder—Azathioprine—Crohn's disease	0.0034	0.00742	CcSEcCtD
Tapentadol—Mediastinal disorder—Azathioprine—Crohn's disease	0.00339	0.0074	CcSEcCtD
Tapentadol—Urinary tract disorder—Mesalazine—Crohn's disease	0.00339	0.00739	CcSEcCtD
Tapentadol—Chills—Azathioprine—Crohn's disease	0.00338	0.00737	CcSEcCtD
Tapentadol—Connective tissue disorder—Mesalazine—Crohn's disease	0.00337	0.00735	CcSEcCtD
Tapentadol—Urethral disorder—Mesalazine—Crohn's disease	0.00336	0.00733	CcSEcCtD
Tapentadol—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00331	0.00721	CcSEcCtD
Tapentadol—Eye disorder—Mesalazine—Crohn's disease	0.0032	0.00699	CcSEcCtD
Tapentadol—Cardiac disorder—Mesalazine—Crohn's disease	0.00318	0.00694	CcSEcCtD
Tapentadol—Angiopathy—Mesalazine—Crohn's disease	0.00311	0.00679	CcSEcCtD
Tapentadol—Euphoric mood—Prednisone—Crohn's disease	0.0031	0.00677	CcSEcCtD
Tapentadol—Immune system disorder—Mesalazine—Crohn's disease	0.0031	0.00676	CcSEcCtD
Tapentadol—Mediastinal disorder—Mesalazine—Crohn's disease	0.00309	0.00674	CcSEcCtD
Tapentadol—Chills—Mesalazine—Crohn's disease	0.00308	0.00671	CcSEcCtD
Tapentadol—Diarrhoea—Mercaptopurine—Crohn's disease	0.00307	0.0067	CcSEcCtD
Tapentadol—Mental disorder—Mesalazine—Crohn's disease	0.003	0.00655	CcSEcCtD
Tapentadol—Tension—Mesalazine—Crohn's disease	0.00293	0.00639	CcSEcCtD
Tapentadol—Nervousness—Mesalazine—Crohn's disease	0.0029	0.00632	CcSEcCtD
Tapentadol—Vomiting—Mercaptopurine—Crohn's disease	0.00285	0.00623	CcSEcCtD
Tapentadol—Rash—Mercaptopurine—Crohn's disease	0.00283	0.00617	CcSEcCtD
Tapentadol—Dermatitis—Mercaptopurine—Crohn's disease	0.00283	0.00617	CcSEcCtD
Tapentadol—Vision blurred—Mesalazine—Crohn's disease	0.00281	0.00614	CcSEcCtD
Tapentadol—Tremor—Mesalazine—Crohn's disease	0.0028	0.0061	CcSEcCtD
Tapentadol—Arthralgia—Azathioprine—Crohn's disease	0.00279	0.00609	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00277	0.00604	CcSEcCtD
Tapentadol—Angioedema—Mesalazine—Crohn's disease	0.00273	0.00595	CcSEcCtD
Tapentadol—Vertigo—Mesalazine—Crohn's disease	0.00268	0.00585	CcSEcCtD
Tapentadol—Syncope—Mesalazine—Crohn's disease	0.00268	0.00584	CcSEcCtD
Tapentadol—Lethargy—Prednisone—Crohn's disease	0.00268	0.00584	CcSEcCtD
Tapentadol—Nausea—Mercaptopurine—Crohn's disease	0.00267	0.00582	CcSEcCtD
Tapentadol—Infection—Azathioprine—Crohn's disease	0.00266	0.0058	CcSEcCtD
Tapentadol—Palpitations—Mesalazine—Crohn's disease	0.00264	0.00575	CcSEcCtD
Tapentadol—Loss of consciousness—Mesalazine—Crohn's disease	0.00262	0.00572	CcSEcCtD
Tapentadol—Osteoarthritis—Prednisone—Crohn's disease	0.00262	0.00572	CcSEcCtD
Tapentadol—Cough—Mesalazine—Crohn's disease	0.0026	0.00568	CcSEcCtD
Tapentadol—Skin disorder—Azathioprine—Crohn's disease	0.0026	0.00567	CcSEcCtD
Tapentadol—Arthralgia—Mesalazine—Crohn's disease	0.00254	0.00554	CcSEcCtD
Tapentadol—Anxiety—Mesalazine—Crohn's disease	0.00253	0.00553	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00252	0.00551	CcSEcCtD
Tapentadol—Irritability—Prednisone—Crohn's disease	0.0025	0.00546	CcSEcCtD
Tapentadol—Hypotension—Azathioprine—Crohn's disease	0.0025	0.00545	CcSEcCtD
Tapentadol—Dry mouth—Mesalazine—Crohn's disease	0.00248	0.00542	CcSEcCtD
Tapentadol—Confusional state—Mesalazine—Crohn's disease	0.00246	0.00536	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00244	0.00532	CcSEcCtD
Tapentadol—Anaphylactic shock—Mesalazine—Crohn's disease	0.00244	0.00531	CcSEcCtD
Tapentadol—Oedema—Mesalazine—Crohn's disease	0.00244	0.00531	CcSEcCtD
Tapentadol—Infection—Mesalazine—Crohn's disease	0.00242	0.00528	CcSEcCtD
Tapentadol—Shock—Mesalazine—Crohn's disease	0.0024	0.00523	CcSEcCtD
Tapentadol—Nervous system disorder—Mesalazine—Crohn's disease	0.00239	0.00521	CcSEcCtD
Tapentadol—Tachycardia—Mesalazine—Crohn's disease	0.00238	0.00519	CcSEcCtD
Tapentadol—Skin disorder—Mesalazine—Crohn's disease	0.00237	0.00516	CcSEcCtD
Tapentadol—Hyperhidrosis—Mesalazine—Crohn's disease	0.00235	0.00514	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00231	0.00505	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00231	0.00504	CcSEcCtD
Tapentadol—Hypotension—Mesalazine—Crohn's disease	0.00228	0.00497	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00222	0.00484	CcSEcCtD
Tapentadol—Feeling abnormal—Azathioprine—Crohn's disease	0.0022	0.00481	CcSEcCtD
Tapentadol—Insomnia—Mesalazine—Crohn's disease	0.0022	0.00481	CcSEcCtD
Tapentadol—Paraesthesia—Mesalazine—Crohn's disease	0.00219	0.00477	CcSEcCtD
Tapentadol—Dyspnoea—Mesalazine—Crohn's disease	0.00217	0.00474	CcSEcCtD
Tapentadol—Somnolence—Mesalazine—Crohn's disease	0.00217	0.00472	CcSEcCtD
Tapentadol—Dyspepsia—Mesalazine—Crohn's disease	0.00214	0.00468	CcSEcCtD
Tapentadol—Decreased appetite—Mesalazine—Crohn's disease	0.00212	0.00462	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.0021	0.00459	CcSEcCtD
Tapentadol—Fatigue—Mesalazine—Crohn's disease	0.0021	0.00458	CcSEcCtD
Tapentadol—Erectile dysfunction—Prednisone—Crohn's disease	0.00209	0.00455	CcSEcCtD
Tapentadol—Constipation—Mesalazine—Crohn's disease	0.00208	0.00454	CcSEcCtD
Tapentadol—Weight decreased—Prednisone—Crohn's disease	0.00205	0.00447	CcSEcCtD
Tapentadol—Depression—Prednisone—Crohn's disease	0.00201	0.0044	CcSEcCtD
Tapentadol—Feeling abnormal—Mesalazine—Crohn's disease	0.00201	0.00438	CcSEcCtD
Tapentadol—Hypersensitivity—Azathioprine—Crohn's disease	0.00197	0.0043	CcSEcCtD
Tapentadol—Urticaria—Mesalazine—Crohn's disease	0.00193	0.00422	CcSEcCtD
Tapentadol—Bradycardia—Prednisone—Crohn's disease	0.00185	0.00403	CcSEcCtD
Tapentadol—Diarrhoea—Azathioprine—Crohn's disease	0.00183	0.00399	CcSEcCtD
Tapentadol—Hallucination—Prednisone—Crohn's disease	0.0018	0.00394	CcSEcCtD
Tapentadol—Hypersensitivity—Mesalazine—Crohn's disease	0.00179	0.00392	CcSEcCtD
Tapentadol—Connective tissue disorder—Prednisone—Crohn's disease	0.00178	0.00389	CcSEcCtD
Tapentadol—Dizziness—Azathioprine—Crohn's disease	0.00177	0.00386	CcSEcCtD
Tapentadol—Asthenia—Mesalazine—Crohn's disease	0.00175	0.00381	CcSEcCtD
Tapentadol—Pruritus—Mesalazine—Crohn's disease	0.00172	0.00376	CcSEcCtD
Tapentadol—Vomiting—Azathioprine—Crohn's disease	0.0017	0.00371	CcSEcCtD
Tapentadol—Eye disorder—Prednisone—Crohn's disease	0.0017	0.0037	CcSEcCtD
Tapentadol—Rash—Azathioprine—Crohn's disease	0.00169	0.00368	CcSEcCtD
Tapentadol—Dermatitis—Azathioprine—Crohn's disease	0.00168	0.00368	CcSEcCtD
Tapentadol—Headache—Azathioprine—Crohn's disease	0.00168	0.00366	CcSEcCtD
Tapentadol—Diarrhoea—Mesalazine—Crohn's disease	0.00167	0.00364	CcSEcCtD
Tapentadol—Angiopathy—Prednisone—Crohn's disease	0.00165	0.00359	CcSEcCtD
Tapentadol—Immune system disorder—Prednisone—Crohn's disease	0.00164	0.00358	CcSEcCtD
Tapentadol—Dizziness—Mesalazine—Crohn's disease	0.00161	0.00351	CcSEcCtD
Tapentadol—Mental disorder—Prednisone—Crohn's disease	0.00159	0.00347	CcSEcCtD
Tapentadol—Nausea—Azathioprine—Crohn's disease	0.00159	0.00347	CcSEcCtD
Tapentadol—Malnutrition—Prednisone—Crohn's disease	0.00158	0.00345	CcSEcCtD
Tapentadol—Vomiting—Mesalazine—Crohn's disease	0.00155	0.00338	CcSEcCtD
Tapentadol—Rash—Mesalazine—Crohn's disease	0.00154	0.00335	CcSEcCtD
Tapentadol—Dermatitis—Mesalazine—Crohn's disease	0.00153	0.00335	CcSEcCtD
Tapentadol—Headache—Mesalazine—Crohn's disease	0.00153	0.00333	CcSEcCtD
Tapentadol—Vision blurred—Prednisone—Crohn's disease	0.00149	0.00325	CcSEcCtD
Tapentadol—Agitation—Prednisone—Crohn's disease	0.00145	0.00317	CcSEcCtD
Tapentadol—Nausea—Mesalazine—Crohn's disease	0.00145	0.00316	CcSEcCtD
Tapentadol—Angioedema—Prednisone—Crohn's disease	0.00144	0.00315	CcSEcCtD
Tapentadol—Vertigo—Prednisone—Crohn's disease	0.00142	0.0031	CcSEcCtD
Tapentadol—Syncope—Prednisone—Crohn's disease	0.00142	0.00309	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisone—Crohn's disease	0.00139	0.00303	CcSEcCtD
Tapentadol—Convulsion—Prednisone—Crohn's disease	0.00137	0.00299	CcSEcCtD
Tapentadol—Arthralgia—Prednisone—Crohn's disease	0.00134	0.00293	CcSEcCtD
Tapentadol—Anxiety—Prednisone—Crohn's disease	0.00134	0.00292	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00134	0.00291	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisone—Crohn's disease	0.00129	0.00281	CcSEcCtD
Tapentadol—Oedema—Prednisone—Crohn's disease	0.00129	0.00281	CcSEcCtD
Tapentadol—Infection—Prednisone—Crohn's disease	0.00128	0.00279	CcSEcCtD
Tapentadol—Shock—Prednisone—Crohn's disease	0.00127	0.00277	CcSEcCtD
Tapentadol—Nervous system disorder—Prednisone—Crohn's disease	0.00126	0.00276	CcSEcCtD
Tapentadol—Tachycardia—Prednisone—Crohn's disease	0.00126	0.00274	CcSEcCtD
Tapentadol—Skin disorder—Prednisone—Crohn's disease	0.00125	0.00273	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisone—Crohn's disease	0.00125	0.00272	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00117	0.00256	CcSEcCtD
Tapentadol—Insomnia—Prednisone—Crohn's disease	0.00117	0.00254	CcSEcCtD
Tapentadol—Paraesthesia—Prednisone—Crohn's disease	0.00116	0.00253	CcSEcCtD
Tapentadol—Dyspepsia—Prednisone—Crohn's disease	0.00113	0.00248	CcSEcCtD
Tapentadol—Decreased appetite—Prednisone—Crohn's disease	0.00112	0.00244	CcSEcCtD
Tapentadol—Fatigue—Prednisone—Crohn's disease	0.00111	0.00242	CcSEcCtD
Tapentadol—Constipation—Prednisone—Crohn's disease	0.0011	0.0024	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisone—Crohn's disease	0.00106	0.00232	CcSEcCtD
Tapentadol—Urticaria—Prednisone—Crohn's disease	0.00102	0.00223	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisone—Crohn's disease	0.000949	0.00207	CcSEcCtD
Tapentadol—Asthenia—Prednisone—Crohn's disease	0.000925	0.00202	CcSEcCtD
Tapentadol—Pruritus—Prednisone—Crohn's disease	0.000912	0.00199	CcSEcCtD
Tapentadol—Diarrhoea—Prednisone—Crohn's disease	0.000882	0.00192	CcSEcCtD
Tapentadol—Dizziness—Prednisone—Crohn's disease	0.000852	0.00186	CcSEcCtD
Tapentadol—Vomiting—Prednisone—Crohn's disease	0.000819	0.00179	CcSEcCtD
Tapentadol—Rash—Prednisone—Crohn's disease	0.000813	0.00177	CcSEcCtD
Tapentadol—Dermatitis—Prednisone—Crohn's disease	0.000812	0.00177	CcSEcCtD
Tapentadol—Headache—Prednisone—Crohn's disease	0.000807	0.00176	CcSEcCtD
Tapentadol—Nausea—Prednisone—Crohn's disease	0.000765	0.00167	CcSEcCtD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000737	0.00401	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.000726	0.00395	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00072	0.00392	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000696	0.00379	CbGpPWpGaD
Tapentadol—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.000688	0.00375	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.000681	0.0037	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.000675	0.00367	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.000675	0.00367	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000674	0.00367	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.000672	0.00365	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000659	0.00359	CbGpPWpGaD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000649	0.00353	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.000647	0.00352	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000634	0.00345	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000632	0.00344	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000623	0.00339	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.000614	0.00334	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.000613	0.00334	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000596	0.00324	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.000592	0.00322	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000573	0.00312	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000572	0.00311	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.000571	0.0031	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000568	0.00309	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000568	0.00309	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000568	0.00309	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.000567	0.00309	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000556	0.00303	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000549	0.00298	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.000549	0.00298	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.000538	0.00293	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000534	0.0029	CbGpPWpGaD
Tapentadol—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	0.000505	0.00275	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.0005	0.00272	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.000484	0.00264	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.000483	0.00263	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.000481	0.00262	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.000479	0.00261	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00047	0.00256	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.000468	0.00255	CbGpPWpGaD
Tapentadol—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000464	0.00253	CbGpPWpGaD
Tapentadol—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.00046	0.0025	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.000454	0.00247	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.000447	0.00243	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000447	0.00243	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.000435	0.00237	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.000425	0.00231	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.000424	0.0023	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000418	0.00228	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000415	0.00226	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.00041	0.00223	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.000407	0.00221	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.0004	0.00218	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.000395	0.00215	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.000382	0.00208	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.000382	0.00208	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.000373	0.00203	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000372	0.00202	CbGpPWpGaD
Tapentadol—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.00037	0.00201	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PLA2G4F—Crohn's disease	0.00037	0.00201	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.000362	0.00197	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000358	0.00195	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000357	0.00194	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000354	0.00192	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000347	0.00189	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.000346	0.00188	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000346	0.00188	CbGpPWpGaD
Tapentadol—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000337	0.00183	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.000335	0.00182	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000335	0.00182	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.000331	0.0018	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000322	0.00175	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.000318	0.00173	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000317	0.00172	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.000315	0.00171	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTMR3—Crohn's disease	0.000314	0.00171	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.00031	0.00169	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000304	0.00165	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PLA2G4F—Crohn's disease	0.0003	0.00163	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000293	0.00159	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000292	0.00159	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.000291	0.00158	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.00029	0.00158	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000289	0.00157	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000283	0.00154	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.000282	0.00153	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.000275	0.00149	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000273	0.00148	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.000272	0.00148	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000269	0.00147	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.000268	0.00146	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.000262	0.00143	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000259	0.00141	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000257	0.0014	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000256	0.00139	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTMR3—Crohn's disease	0.000255	0.00139	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.000254	0.00138	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.000251	0.00137	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000251	0.00136	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000248	0.00135	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.000247	0.00134	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000246	0.00134	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000246	0.00134	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—FADS1—Crohn's disease	0.000245	0.00133	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.000241	0.00131	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000239	0.0013	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000237	0.00129	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.000233	0.00127	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.000232	0.00126	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000232	0.00126	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.00023	0.00125	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GPX4—Crohn's disease	0.000229	0.00125	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000225	0.00122	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GCKR—Crohn's disease	0.000221	0.0012	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.00022	0.0012	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.000217	0.00118	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000216	0.00118	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000215	0.00117	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.000211	0.00115	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00021	0.00114	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000209	0.00114	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000209	0.00114	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.000205	0.00111	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000204	0.00111	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.000204	0.00111	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000204	0.00111	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000203	0.00111	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000202	0.0011	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—FADS1—Crohn's disease	0.000199	0.00108	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000197	0.00107	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000197	0.00107	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000191	0.00104	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GPX4—Crohn's disease	0.000186	0.00101	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000186	0.00101	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.000185	0.00101	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000184	0.000999	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GCKR—Crohn's disease	0.00018	0.000979	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000179	0.000975	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000179	0.000974	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.000177	0.000962	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.000173	0.000941	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000172	0.000937	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000172	0.000936	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—IL6—Crohn's disease	0.000171	0.000928	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000167	0.000907	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR6—Crohn's disease	0.000166	0.000905	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000163	0.000886	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000156	0.000851	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	0.000155	0.000843	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000151	0.000823	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RBX1—Crohn's disease	0.00015	0.000818	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.000148	0.000805	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000146	0.000797	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR6—Crohn's disease	0.000146	0.000793	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000143	0.000777	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	0.000141	0.000768	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RBX1—Crohn's disease	0.000132	0.000718	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.000132	0.000718	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000131	0.000713	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.00013	0.000706	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	0.00013	0.000706	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	0.000129	0.0007	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000129	0.000699	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	0.000128	0.000698	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	0.000128	0.000696	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000127	0.000693	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL3—Crohn's disease	0.000125	0.000678	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR6—Crohn's disease	0.000123	0.000671	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000121	0.000657	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.000121	0.000656	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTMR3—Crohn's disease	0.00012	0.000653	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	0.000116	0.000629	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000112	0.000612	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	0.000112	0.00061	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RBX1—Crohn's disease	0.000111	0.000606	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.00011	0.0006	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.00011	0.000596	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000109	0.000596	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTMR3—Crohn's disease	0.000109	0.000595	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL3—Crohn's disease	0.000109	0.000595	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000109	0.000595	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000109	0.00059	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	0.000106	0.000575	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	0.000104	0.000567	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	9.99e-05	0.000544	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	9.94e-05	0.000541	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	9.77e-05	0.000532	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	9.6e-05	0.000522	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	9.58e-05	0.000521	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	9.48e-05	0.000516	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	9.44e-05	0.000513	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—FADS1—Crohn's disease	9.35e-05	0.000509	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL3—Crohn's disease	9.24e-05	0.000503	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	9.14e-05	0.000497	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	9.07e-05	0.000494	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	8.94e-05	0.000486	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	8.76e-05	0.000477	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GPX4—Crohn's disease	8.75e-05	0.000476	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	8.74e-05	0.000475	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	8.72e-05	0.000474	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—FADS1—Crohn's disease	8.6e-05	0.000468	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—FADS1—Crohn's disease	8.52e-05	0.000464	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GCKR—Crohn's disease	8.45e-05	0.00046	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	8.27e-05	0.00045	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	8.11e-05	0.000441	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	8.1e-05	0.000441	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GPX4—Crohn's disease	8.05e-05	0.000438	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GPX4—Crohn's disease	7.98e-05	0.000434	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	7.96e-05	0.000433	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GCKR—Crohn's disease	7.78e-05	0.000423	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	7.72e-05	0.00042	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GCKR—Crohn's disease	7.71e-05	0.000419	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	7.66e-05	0.000417	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	7.4e-05	0.000403	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	7.37e-05	0.000401	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALB—Crohn's disease	7.05e-05	0.000383	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	6.99e-05	0.00038	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	6.72e-05	0.000366	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	6.47e-05	0.000352	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—Crohn's disease	6.16e-05	0.000335	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TYK2—Crohn's disease	6.16e-05	0.000335	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.04e-05	0.000329	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—JAK2—Crohn's disease	5.87e-05	0.000319	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—Crohn's disease	5.73e-05	0.000311	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.51e-05	0.0003	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TYK2—Crohn's disease	5.4e-05	0.000294	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	5.36e-05	0.000292	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.29e-05	0.000288	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—JAK2—Crohn's disease	5.15e-05	0.00028	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—Crohn's disease	5.1e-05	0.000277	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—Crohn's disease	5.01e-05	0.000272	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.82e-05	0.000262	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	4.7e-05	0.000256	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TYK2—Crohn's disease	4.56e-05	0.000248	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—Crohn's disease	4.47e-05	0.000243	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—JAK2—Crohn's disease	4.35e-05	0.000237	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STAT3—Crohn's disease	4.31e-05	0.000234	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	3.97e-05	0.000216	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STAT3—Crohn's disease	3.78e-05	0.000206	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—Crohn's disease	3.78e-05	0.000205	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STAT3—Crohn's disease	3.19e-05	0.000174	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—Crohn's disease	3.01e-05	0.000164	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—Crohn's disease	2.69e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—Crohn's disease	2.64e-05	0.000144	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—Crohn's disease	2.47e-05	0.000135	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—Crohn's disease	2.45e-05	0.000133	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—Crohn's disease	2.35e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—Crohn's disease	2.23e-05	0.000121	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.17e-05	0.000118	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—Crohn's disease	2.15e-05	0.000117	CbGpPWpGaD
